Search for: "Bristol-Myers Squibb Company " Results 221 - 240 of 464
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Apr 2014, 9:55 pm by Patent Docs
Bristol-Myers Squibb Company v. [read post]
14 Mar 2014, 1:02 pm
The individual filed suit in Cook County Circuit Court against Bristol-Myers Squibb Co., Sanofi-Aventis US LLC, Sanofi-Aventis US Inc., and Sanofi-Synthelabo Inc. in a claim of strict product liability, manufacturing defect, negligence, and failure to warn. [read post]
7 Jan 2014, 9:22 am by David Bernstein
Bristol Myers Squibb and other companies were inundated by silicone breast implant cases, and plaintiffs had managed to snucker a few juries into returning large verdicts against the defendants. [read post]
2 Jan 2014, 8:08 am by Schachtman
  Bristol Myers Squibb and other companies were inundated by silicone breast implant cases, and plaintiffs had managed to snucker a few juries into returning large verdicts against the defendants. [read post]
19 Dec 2013, 1:03 pm by Schachtman
Bristol Myers Squibb Co., No. 96 689 CIV ORL 19B, 1998 WL 812318 (M.D. [read post]
12 Dec 2013, 7:12 am
 In the meantime, here they are in outline:Case C‑443/12, Actavis Group PTC EHF, Actavis UK Ltd v Sanofi, Sanofi Pharma Bristol-Myers Squibb SNC intervening, noted on The SPC Blog here. [read post]
5 Aug 2013, 9:59 pm by Patent Docs
The UK High Court recently gave its judgment in the case of Merck, Sharp & Dohme Corp. and Bristol-Myers Squibb Pharmaceuticals Ltd (collectively referred to in the judgement as BMS) v Teva Pharma B.V. and Teva UK Ltd (Teva) (decision). [read post]
1 Aug 2013, 9:29 am by Derek T. Braslow
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]
29 Jul 2013, 2:24 am
 Unfortunately,without any thumbs, he was unable to forwardthem to the true recipient, Bristol-Myers Squibb When the parties engaged in correspondence, Teva refused to divulge its launch plans as it considered these plans confidential. [read post]
28 Jul 2013, 9:29 am by Spencer Aronfeld
  Byetta, now sold by Bristol-Myers Squibb and AstraZeneca, was approved in 2005 and contained a warning about pancreatitis. [read post]
14 Jun 2013, 9:22 pm by Patent Docs
Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff; and Paul Golian, Assistant General Counsel at Bristol-Myers Squibb Company will consider such questions as: • How many and which existing gene patents will be challenged in post-grant proceedings at the USPTO? [read post]
14 Jun 2013, 6:23 pm
The Food and Drug Administration said it is considering setting up a study, either through the agency or the companies, that looks deeper into whether medicines for Type 2 diabetes, including Merck’s Januvia and Bristol Myers-Squibb Co. [read post]
12 Jun 2013, 12:50 pm by Tom Lamb
The concerns relate to a number of widely prescribed GLP-1–based therapies, the 2 injectable GLP-1 agonists, exenatide (Byetta, Amylin/Lilly) and liraglutide (Victoza, Novo Nordisk), and the oral DPP-4 inhibitors sitagliptin, saxagliptin (Ongylza, AstraZeneca/Bristol-Myers Squibb), and linagliptin (Tradjenta, Boehringer Ingelheim/Lilly). [read post]
10 Jun 2013, 11:23 am
Thakur began his work at Ranbaxy in early 2004 after he was recruited from the brand-name pharmaceutical company Bristol-Myers Squibb (BMY) based out of New Jersey. [read post]
6 Jun 2013, 5:00 am by Bexis
Bristol-Myers Squibb Co., No. 12 Civ. 2238 (JPO), slip op. [read post]
5 Jun 2013, 5:29 am by Schachtman
Bristol-Myers Squibb, 97 F. [read post]